July 28, 2025 · Form 4 insider transaction
Barrett Elizabeth A. bought 87,615 shares of UROGEN PHARMA LTD at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each performance stock unit represents a contingent right to receive one ordinary share of the Issuer.; Represents performance stock units ("PSUs") granted to the reporting person on January 31, 2024 that were earned upon the achievement of a corporate milestone event. These PSUs remain subject to continued service through December 31, 2025, at which time they will vest and settle in ordinary shares.